Indeed, the suppression of the expression of MHC-I is known to prevent both the antitumor effect of type II IFN response and the infiltration of CD8+ T cell, enabling tumor cells to evade recognition and destruction by cytotoxic T lymphocytes (50, 51). This evidence concerns the gene CD8A and neoplasm.